{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-30",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 10879
    }
  },
  "results": [
    {
      "safetyreportversion": "1",
      "safetyreportid": "10021468",
      "primarysourcecountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20141002",
      "reporttype": "1",
      "serious": "1",
      "seriousnessdisabling": "1",
      "receivedateformat": "102",
      "receivedate": "20140318",
      "receiptdateformat": "102",
      "receiptdate": "20140318",
      "fulfillexpeditecriteria": "2",
      "primarysource": {
        "reportercountry": "US"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "40",
        "patientonsetageunit": "801",
        "patientweight": "55.79",
        "patientsex": "2",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Blepharitis"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "LATISSE",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugindication": "GROWTH OF EYELASHES",
            "drugstartdateformat": "102",
            "drugstartdate": "20120307",
            "drugenddateformat": "102",
            "drugenddate": "20130115",
            "drugadditional": "2",
            "openfda": {
              "application_number": [
                "NDA022369"
              ],
              "brand_name": [
                "LATISSE"
              ],
              "generic_name": [
                "BIMATOPROST"
              ],
              "manufacturer_name": [
                "Allergan, Inc."
              ],
              "product_ndc": [
                "0023-3616"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "OPHTHALMIC"
              ],
              "substance_name": [
                "BIMATOPROST"
              ],
              "rxcui": [
                "1041495",
                "1041497"
              ],
              "spl_id": [
                "f3f30669-e9b1-406b-b6fc-30c520f8ffb3"
              ],
              "spl_set_id": [
                "34f83d9d-2c64-463e-8a90-9a460fedfead"
              ],
              "package_ndc": [
                "0023-3616-71",
                "0023-3616-05",
                "0023-3616-70"
              ],
              "nui": [
                "N0000175454",
                "M0017805"
              ],
              "pharm_class_epc": [
                "Prostaglandin Analog [EPC]"
              ],
              "pharm_class_cs": [
                "Prostaglandins [CS]"
              ],
              "unii": [
                "QXS94885MZ"
              ]
            }
          }
        ]
      }
    }
  ]
}